SCHEMBL537445

SCHEMBL537445

C#CCCCCCNC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.54
CYP2D6 P10635 2/20 0.54
MAPT P10636 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
HSD17B10 Q99714 1/20 0.54
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.39
HIF1A Q16665 1/20 0.39
PRMT1 Q99873 1/20 0.39
EPHX2 P34913 3/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
CYP3A4 P08684 1/20 0.37
ADRA1A P35348 1/20 0.36
EPHX1 P07099 2/20 0.35
ALDH1A2 O94788 1/20 0.35
ALDH2 P05091 1/20 0.35
ALDH1A3 P47895 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28312759 1.00 CYP1A2 (0.54) CYP1A2CYP2D6MAPTCYP2C9CYP2C19
SCHEMBL20415293 0.98 CYP1A2 (0.50) CYP1A2CYP2D6MAPTCYP2C9CYP2C19
SCHEMBL16499782 0.91
SCHEMBL476298 0.81
SCHEMBL28569684 0.81 KDM4E (0.55) ALDH1A1KDM4EMAPK1HIF1APRMT1
SCHEMBL453216 0.81 KDM4E (0.55) ALDH1A1KDM4EMAPK1HIF1APRMT1
SCHEMBL2029681 0.81 KDM4E (0.55) ALDH1A1KDM4EMAPK1HIF1APRMT1
SCHEMBL20836564 0.81 KDM4E (0.55) ALDH1A1KDM4EMAPK1HIF1APRMT1
SCHEMBL30541972 0.81 KDM4E (0.55) ALDH1A1KDM4EMAPK1HIF1APRMT1
SCHEMBL15871737 0.81 KDM4E (0.55) ALDH1A1KDM4EMAPK1HIF1APRMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0938470-B1 AQUEOUS SYNTHESIS OF IODOPROPARGYL CARBAMATE TROY TECHNOLOGY CORP INC (US) 2001-09-26 EP claimed
EP-4334307-A1 CDK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-03-13 EP disclosed
WO-2022236058-A1 CDK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-11-10 WO disclosed
EP-2473481-A1 PROCESS FOR PREPARING IODOPROPARGYL COMPOUNDS Lanxess Deutschland GmbH (DE) 2012-07-11 EP disclosed
EP-2289873-B1 Process for the preparation of iodopropargyl compounds LANXESS DEUTSCHLAND GMBH (DE) 2012-02-08 EP disclosed
WO-2011023757-A1 PROCESS FOR PREPARING IODOPROPARGYL COMPOUNDS LANXESS DEUTSCHLAND GMBH (DE) 2011-03-03 WO disclosed
EP-2289873-A1 Process for the preparation of iodopropargyl compounds LANXESS Deutschland GmbH (DE) 2011-03-02 EP disclosed